Safety and Efficacy of RK0202 in Oral Mucositis
NCT00230191
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Mouth Diseases
Mouth Ulcers
Oral Mucositis
Head and Neck Cancer
Interventions
DRUG:
RK-0202
Sponsor
RxKinetix